Excluv 625 Tablet is a combination antibiotic containing Amoxycillin 500mg and Clavulanic Acid 125mg, designed to treat a wide range of bacterial infections. Amoxycillin, a penicillin-type antibiotic, works by inhibiting the synthesis of bacterial cell walls, leading to the destruction of susceptible bacteria. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing certain bacteria from deactivating Amoxycillin, thereby enhancing its effectiveness against resistant strains. This synergistic combination makes Excluv 625 effective against infections caused by beta-lactamase-producing bacteria, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sinusitis. It is generally prescribed when single-agent antibiotics are insufficient or when resistance is suspected. Excluv 625 should be taken orally, preferably with food to reduce gastrointestinal discomfort. Common side effects may include nausea, diarrhea, and allergic reactions; patients should inform their healthcare provider of any history of penicillin allergy. It is important to complete the full prescribed course to prevent the development of resistance. Excluv 625 is contraindicated in patients with hypersensitivity to penicillins or clavulanic acid. Always consult a healthcare professional before use to ensure appropriate indication and dosing.